Literature DB >> 7438387

Beat-to-beat left ventricular performance assessed from the equilibrium cardiac blood pool using a computerized nuclear probe.

H J Berger, R A Davies, W P Batsford, P B Hoffer, A Gottschalk, B L Zaret.   

Abstract

The feasibility, accuracy and reproducibility of continuous beat-to-beat evaluation of left ventricular performance with a computerized nonimaging scintillation probe was assessed in 71 patients. This portable instrument has enough sensitivity to generate a real-time relative left ventricular volume curve using the labeled equilibrium blood pool without electrocardiographic gating. The probe was positioned at the left ventricular and background regions of interest using a systematic series of computerized algorithms and operator routines that were developed and standardized during the initial phase of this study. In each patient, left ventricular ejection fraction was calculated manually from the strip-chart recording in 10 consecutive sinus beats. Beat-to-beat left ventricular ejection fraction determined by the probe correlated well with first-pass studies obtained using a computerized multicrystal scintillation camera (r = 0.92). There was no systematic over- or underestimation, and the correlation was evident over a wide range of first-pass values (15-81%). There was excellent agreement between initial and repeat analyses (n = 58, r = 0.97) and between initial and repeat studies (n = 48, r = 0.94). The absolute variability of beat-to-beat ejection fraction measurements determined from all 710 beats was +/- 5.9% (expressed in ejection fraction units as +/- 2 SD). This technique should provide a reliable means of addressing pathophysiologic questions that require sampling of data directly on a beat-to-beat basis.

Entities:  

Mesh:

Year:  1981        PMID: 7438387     DOI: 10.1161/01.cir.63.1.133

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Effects of nifedipine on cardiac function in patients with coronary artery disease evaluated with ambulatory radionuclide monitoring.

Authors:  H Kambara; I H Mohiuddin; N Tamaki; T Fudo; M Hayashi; R Nohara; J Konishi; C Kawai
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Comparison of gating methods for the real-time analysis of left ventricular function in nonimaging blood pool studies.

Authors:  B B Beard; J R Stewart; R G Shiavi; C H Lorenz
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

3.  Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology.

Authors:  E G DePuey; S Port; F J Wackers; A Rozanski; E H Botvinick; M W Dae; N Tamaki
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

4.  A haemodynamic and radionuclide assessment of diltiazem in coronary heart disease.

Authors:  B Silke; S K Sharma; S P Verma; K A Midtbo; G Reynolds; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

5.  Assessment of left ventricular function in coronary artery disease with the nuclear probe during intervention studies.

Authors:  A Lahiri; M J Bowles; R I Jones; J C Crawley; E B Raftery
Journal:  Br Heart J       Date:  1984-10

6.  Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.

Authors:  P DasGupta; A Lahiri
Journal:  Clin Investig       Date:  1992

7.  Beat-to-beat assessment of left ventricular ejection in atrial fibrillation.

Authors:  H Benjelloun; R Itti; L Philippe; J M Lorgeron; M Brochier
Journal:  Eur J Nucl Med       Date:  1983

8.  Measurement of effects of the Chinese herbal medicine higenamine on left ventricular function using a cardiac probe.

Authors:  X J Liu; H N Wagner; S Tao
Journal:  Eur J Nucl Med       Date:  1983

9.  Immediate effects of bumetanide on systemic haemodynamics and left ventricular volume in acute and chronic heart failure.

Authors:  S P Verma; B Silke; G Reynolds; P Muller; M A Frais; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

10.  A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.

Authors:  B Silke; S P Verma; M A Frais; G Reynolds; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.